EL
Essex LLC’s Novo Nordisk NVO Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $358K | Buy |
5,194
+643
| +14% | +$44.4K | 0.07% | 121 |
|
|
2025
Q1 | $316K | Hold |
4,551
| – | – | 0.07% | 124 |
|
|
2024
Q4 | $391K | Sell |
4,551
-310
| -6% | -$26.7K | 0.08% | 114 |
|
|
2024
Q3 | $579K | Hold |
4,861
| – | – | 0.12% | 103 |
|
|
2024
Q2 | $694K | Buy |
4,861
+177
| +4% | +$25.3K | 0.16% | 96 |
|
|
2024
Q1 | $601K | Buy |
4,684
+90
| +2% | +$11.6K | 0.14% | 96 |
|
|
2023
Q4 | $475K | Buy |
4,594
+10
| +0.2% | +$1.03K | 0.12% | 107 |
|
|
2023
Q3 | $417K | Buy |
4,584
+2,384
| +108% | +$217K | 0.12% | 107 |
|
|
2023
Q2 | $356K | Sell |
2,200
-262
| -11% | -$42.4K | 0.1% | 111 |
|
|
2023
Q1 | $333K | Hold |
2,462
| – | – | 0.1% | 116 |
|
|
2022
Q4 | $333K | Hold |
2,462
| – | – | 0.1% | 116 |
|
|
2022
Q3 | $245K | Sell |
2,462
-50
| -2% | -$4.98K | 0.08% | 129 |
|
|
2022
Q2 | $280K | Hold |
2,512
| – | – | 0.09% | 127 |
|
|
2022
Q1 | $279K | Hold |
2,512
| – | – | 0.08% | 140 |
|
|
2021
Q4 | $281K | Sell |
2,512
-438
| -15% | -$49K | 0.08% | 147 |
|
|
2021
Q3 | $283K | Buy |
+2,950
| New | +$283K | 0.08% | 148 |
|